Status:
UNKNOWN
Platelet Transfusion in Acute Intracerebral Hemorrhage
Lead Sponsor:
University of Oulu
Collaborating Sponsors:
University of Helsinki
Conditions:
Intracerebral Hemorrhage
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
* To prove whether use of antiplatelet agents results into a rapid enlargement of hematoma after onset of acute intracerebral hemorrhage. * To prove the efficacy and safety of platelet transfusion for...
Detailed Description
* Hematoma growth is a well-known powerful determinant of mortality and poor outcome after intracerebral hemorrhage. * Some observations suggest that previous use of antiplatelet agents associates wit...
Eligibility Criteria
Inclusion
- being on either aspirin or clopidogrel or a combination of aspirin and dipyridamole
- acute primary ICH
- \> 17 years
- admitted within 6 h after onset of ICH
- ICH score \< 4
Exclusion
- other type of ICH than acute primary intracerebral hemorrhage
- patients who need neurosurgery
- life expectancy less than 3 months due to comorbid disorders
- confirmed malignant disease (cancer)
- confirmed acute myocardial infarction
- hepatitis and/liver cirrhosis
- renal failure
- infectious disease (HIV, endocarditis etc.)
- current or previous hematologic disease
- women of childbearing age if pregnant
- participation in another study within the preceding 30 days
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2014
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00699621
Start Date
January 1 2009
End Date
December 1 2014
Last Update
July 2 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Neurology, Oulu University Hospital
Oulu, Finland, 90029 OYS